Marketing research of medicines used to provide qualified medical care for military patients with chronic respiratory diseases

Keywords: servicemen, qualified therapeutic care, medicines, marketing analysis, antibiotic therapy.

Abstract

Introduction. Given the leading place of chronic respiratory diseases in the morbidity of servicemen (80-90% of the total number of infectious diseases per year), the quality of medical care and its optimization is becoming increasingly medical and social. There is a rapid development of tolerance of various pathogens to existing antibacterial drugs, allergic and other side effects when using drugs. Increasing the arsenal of medicines on the Ukrainian market does not significantly improve the situation with regard to respiratory diseases in the military.

The purpose. Conduct a marketing analysis of the domestic market of medicines used to provide qualified medical care to servicemen with chronic bronchitis.

Materials and methods. The materials of the study were taken from a database of drugs registered in Ukraine, presented on the official website of the State Institution "State Expert Center" of the Ministry of Health of Ukraine. System-review, bibliographic, retrospective, and marketing analyzes were used to conduct the drug study.

Results. It is established that in terms of the frequency of use in the treatment of servicemen with chronic bronchitis among the total number of drugs, antibacterial agents for systemic use occupy the leading third place in the number of international non-proprietary names and first place in the world. The marketing analysis of the domestic pharmaceutical market of antibacterial drugs for the provision of qualified medical care to sick servicemen with chronic bronchitis showed priority positions in the breadth of the range of CJSC "Pharmaceutical Company" Darnytsia ", LLC" FC "Health", corporation forms. In the group of antiviral drugs in demand in the treatment of chronic bronchitis has inositol pronabex imported production, dominated by solid dosage forms of tablets. The majority of mucolytics are drugs of foreign pharmaceutical companies from 10 countries, the leaders among the producing countries are Germany and India.

Conclusions. The nomenclature of medicines was used to provide qualified medical care to sick servicemen with chronic bronchitis, presented on the domestic pharmaceutical market, has been studied. The geography of suppliers of medicines of certain groups is studied. The main part of the range of medicines presented on the market are drugs of foreign pharmaceutical companies. It has been established that the dominant dosage forms in the studied groups of drugs on the modern market are tablets.

Author Biographies

O. V. Plieshkova , Ukrainian Military Medical Academy

Lieutenant Colonel of the Medical Service, Candidate of Pharmaceutical Sciences, Senior Lecturer of the Department of Military Pharmacy of the Ukrainian Military Medical Academy

O. V. Bielozorova, Ukrainian Military Medical Academy

Lieutenant Colonel of the Medical Service, Candidate of Pharmaceutical Sciences, Head of the Scientific and Organizational Department of the Ukrainian Military Medical Academy

A. V. Nikityuk, 71 military mobile hospitals

senior lieutenant of the medical service, Head of the medical supply department of 71 military mobile hospitals

References

Klyachkina, I.L. (2020). Khronicheskiy bronkhit: farmakoterapevticheskiy fokus na gipersensitivnyy komponent kashlya. Consilium Medicum, 22(3), 46-54. doi: 10.26442/20751753.2020.3.200055. [In Russian].

Voronenko, YU.V. & Moskalenko, V.F. (Eds.). (2015). Sotsialna medytsyna ta orhanizatsiya zdorovya: pidruchnyk. Ternopil: Ukrmedknyha. [In Ukrainian].

National Institute for Health and Care Exellence. Multimorbidity: clinical assessment and management, in press. (2016). Retrieved from http://www.nice.org.uk/guidance/indevelopment/gid-cgwave0704/document.

Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. (2018). Retrieved from https://goldcopd.org/wp-content/uploads/2017/11/GOLD-2018-v6.0-FINAL-revised-20-Nov_WMS.pdf

Holub, A.H., Khomutetska, N.I., & Prytula, R.L. (2004). Suchasni pidkhody shchodo ratsionalnoho vykorystannya likarskykh zasobiv v umovakh viyskovykh likuvalnykh zakladiv: navch. posib. Kyyiv: UVMA. [In Ukrainian].

Stefanyuk, M.F. (1999). Morfofunktsionalnyy stan bronkhiv, zminy zahalnoho imunitetu ta nespetsyfichnoho klitynnoho zakhystu lehen pry povtornykh bronkhopnevmoniyakh u viyskovosluzhbovtsiv strokovoyi sluzhby. (Master's thesis). AMN Ukrayiny, In-t ftyziatriyi i pulʹmonolohiyi im. F. H. Yanovsʹkoho, Kyiv. [In Ukrainian].

Ukraine healthcare and pharmaceutical industries overview. (2015). Retrieved from http://igar.ua/eng/wp-content/uploads/2015/11/Healthcare-and-PharmaIndustries-Overview-2015.pdf.

Strachunskyy, L.S., Belousov, YU.B., & Kozlov S.N. (2000). Antybakteryalnaya terapiya: prakticheskoye rukovodstvo. M. [In Russian].

Posokhova, K.A., & Viktorova, O.P. (Eds.). (2005). Antybiotyky (vlastyvosti, zastosuvannya, vzayemodiya): navch. posib. Ternopil: TDMU. [In Ukrainian].

Kovalenko, V.M., & Viktorova O.P. (Eds.). (2010). Kompendyum 2010. Lekarstvennye preparaty. K.: MORION. [In Ukrainian].

Dovidnyk likarskykh zasobiv Ukrayiny 2018 roku, yakyy mistyt povnyy perelik likarskykh zasobiv, dozvolenykh dlya zastosuvannya v Ukrayini za stanom na 01.03.2018 roku. (2018). Retrieved from http://www.drlz.com.ua/ibp/ddsite.nsf/all/shlist?opendocument . [In Ukrainian].

Published
2021-10-11
How to Cite
Plieshkova , O. V., Bielozorova, O. V., & Nikityuk, A. V. (2021). Marketing research of medicines used to provide qualified medical care for military patients with chronic respiratory diseases. Ukrainian Journal of Military Medicine, 2(3), 103-113. https://doi.org/10.46847/ujmm.2021.3(2)-103